Pfizer, BioNTech begin German part of COVID vaccine study Medical Dialogues Bureau13 Sep 2020 3:30 AM GMTGermany's vaccines regulator, the Paul Ehrlich Institute, gave the approval for the Phase 2/3 trial of the experimental vaccine known as BNT162b2,...
Pfizer-BioNTech potential COVID vaccine shows promise in second early trial Medical Dialogues Bureau1 Aug 2020 4:15 AM GMTNew York: German biotech BioNTech and U.S. drugmaker Pfizer Inc recently said data from an early-stage trial of their experimental coronavirus vaccine ...
